BofA Adjusts Elevance Health (ELV) Target to Reflect Higher Sector Valuations [Yahoo! Finance]
Elevance Health, Inc. (ELV)
Company Research
Source: Yahoo! Finance
On December 16, BofA lifted its price target on Elevance Health, Inc. (NYSE:ELV) to $385 from $370 and kept a Neutral rating. The firm noted that its higher target reflects richer multiples across the peer group. Elevance Health, Inc. (NYSE:ELV)'s third-quarter results showed steady execution. The benefit expense ratio landed where management expected it to. Results included about $1 of favorable items below the line, but the core business tracked closely with the outlook shared last quarter. Management reaffirmed 2025 adjusted EPS of about $30. It continues to view $27 as the right earnings baseline once roughly $3 of nonrecurring items are stripped out. The focus remains on integrating recent acquisitions. Capital returns are also front and center, with share repurchases a priority. Total operating revenue reached $50.1 billion for the quarter, up 12% year over year. Growth came from higher premium yields, recently closed deals, and rising Medicare Advantage membership. That
Show less
Read more
Impact Snapshot
Event Time:
ELV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ELV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ELV alerts
High impacting Elevance Health, Inc. news events
Weekly update
A roundup of the hottest topics
ELV
News
- Elevance Health (NYSE:ELV) had its price target lowered by analysts at Morgan Stanley from $359.00 to $352.00. They now have an "equal weight" rating on the stock.MarketBeat
- Insiders At Elevance Health Sold US$3.5m In Stock, Alluding To Potential Weakness [Yahoo! Finance]Yahoo! Finance
- Elevance Health Reflects On The Changed Role of Health Plans [Yahoo! Finance]Yahoo! Finance
- Elevance Health Reflects On The Changed Role of Health PlansBusiness Wire
- AM Best Takes Various Credit Rating Actions on Elevance Health, Inc. and Most of Its SubsidiariesBusiness Wire
ELV
Earnings
- 10/21/25 - Beat
ELV
Sec Filings
- 12/10/25 - Form 8-K
- 11/21/25 - Form 3/A
- 11/10/25 - Form 8-K
- ELV's page on the SEC website